✦ LIBER ✦

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

✍ Scribed by Robert L. Coleman; William E. Brady; D. Scott McMeekin; Peter G. Rose; John T. Soper; Samuel S. Lentz; James S. Hoffman; Mark S. Shahin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of belinostat and

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II evaluation of mifepristone in

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A phase II evaluation of AMG 102 (rilotu

✍ Martin, Lainie P.; Sill, Michael; Shahin, Mark S.; Powell, Matthew; DiSilvestro, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 246 KB

A phase II evaluation of motesanib (AMG

✍ Schilder, R.J.; Sill, M.W.; Lankes, H.A.; Gold, M.A.; Mannel, R.S.; Modesitt, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase II evaluation of bortezomib in t

✍ Carol Aghajanian; John A. Blessing; Kathleen M. Darcy; Gary Reid; Koen DeGeest; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 589 KB